ATE206428T1 - Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe - Google Patents
Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffeInfo
- Publication number
- ATE206428T1 ATE206428T1 AT97903437T AT97903437T ATE206428T1 AT E206428 T1 ATE206428 T1 AT E206428T1 AT 97903437 T AT97903437 T AT 97903437T AT 97903437 T AT97903437 T AT 97903437T AT E206428 T1 ATE206428 T1 AT E206428T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- spiro
- active ingredients
- therapeutic active
- ketal derivatives
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 abstract 1
- 102000003141 Tachykinin Human genes 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 108060008037 tachykinin Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9603137.2A GB9603137D0 (en) | 1996-02-15 | 1996-02-15 | Therapeutic agents |
| PCT/GB1997/000383 WO1997030055A1 (en) | 1996-02-15 | 1997-02-12 | Spiro-ketal derivatives and their use as therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE206428T1 true ATE206428T1 (de) | 2001-10-15 |
Family
ID=10788765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97903437T ATE206428T1 (de) | 1996-02-15 | 1997-02-12 | Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6127365A (de) |
| EP (1) | EP0880528B1 (de) |
| JP (1) | JP2000505442A (de) |
| AT (1) | ATE206428T1 (de) |
| AU (1) | AU716691B2 (de) |
| DE (1) | DE69707104T2 (de) |
| ES (1) | ES2163730T3 (de) |
| GB (1) | GB9603137D0 (de) |
| WO (1) | WO1997030055A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9625843D0 (en) * | 1996-12-12 | 1997-01-29 | Merck & Co Inc | Phenyl spiroethercycloalkyl tachykinn receptor antagonists |
| US5929094A (en) * | 1996-10-25 | 1999-07-27 | Merck & Co., Inc. | Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists |
| US6335364B1 (en) * | 1998-06-29 | 2002-01-01 | Parker Hughes Institute | Synthetic spiroketal pyranes as potent anti-cancer agents |
| US7041280B2 (en) | 2001-06-29 | 2006-05-09 | Genzyme Corporation | Aryl boronate functionalized polymers for treating obesity |
| US6858592B2 (en) | 2001-06-29 | 2005-02-22 | Genzyme Corporation | Aryl boronic acids for treating obesity |
| US20040220153A1 (en) * | 2002-09-24 | 2004-11-04 | Jost-Price Edward Roydon | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| WO2004030618A2 (en) * | 2002-09-24 | 2004-04-15 | Combinatorx, Incorporated | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| DE102007010077B4 (de) * | 2007-02-28 | 2010-04-08 | RUHR-UNIVERSITäT BOCHUM | [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren |
| ES2794801T3 (es) * | 2015-10-23 | 2020-11-19 | Esteve Pharmaceuticals Sa | Compuestos oxaazaespíricos con actividad contra el dolor |
| US11425169B2 (en) | 2016-03-11 | 2022-08-23 | Netskope, Inc. | Small-footprint endpoint data loss prevention (DLP) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2099233A1 (en) * | 1992-06-29 | 1993-12-30 | Conrad P. Dorn | Morpholine and thiomorpholine tachykinin receptor antagonists |
| US5719147A (en) * | 1992-06-29 | 1998-02-17 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
| DE69412067T2 (de) * | 1993-01-28 | 1999-03-25 | Merck & Co., Inc., Rahway, N.J. | Substituierte spiro-azaringen als tachykinine rezeptor antagonisten |
| JP2832754B2 (ja) * | 1993-03-04 | 1998-12-09 | ファイザー・インク. | サブスタンスpアンタゴニストとしてのスピロアザ環式誘導体 |
| JPH08511522A (ja) * | 1993-06-07 | 1996-12-03 | メルク エンド カンパニー インコーポレーテッド | ニューロキニンアンタゴニストとしてのスピロ置換アザ環 |
| US5434158A (en) * | 1994-04-26 | 1995-07-18 | Merck & Co., Inc. | Spiro-substituted azacycles as neurokinin-3 antagonists |
| GB9426103D0 (en) * | 1994-12-23 | 1995-02-22 | Merck Sharp & Dohme | Therapeutic agents |
-
1996
- 1996-02-15 GB GBGB9603137.2A patent/GB9603137D0/en active Pending
-
1997
- 1997-02-12 US US09/125,226 patent/US6127365A/en not_active Expired - Fee Related
- 1997-02-12 JP JP9529086A patent/JP2000505442A/ja active Pending
- 1997-02-12 EP EP97903437A patent/EP0880528B1/de not_active Expired - Lifetime
- 1997-02-12 WO PCT/GB1997/000383 patent/WO1997030055A1/en not_active Ceased
- 1997-02-12 AU AU17992/97A patent/AU716691B2/en not_active Ceased
- 1997-02-12 DE DE69707104T patent/DE69707104T2/de not_active Expired - Fee Related
- 1997-02-12 AT AT97903437T patent/ATE206428T1/de not_active IP Right Cessation
- 1997-02-12 ES ES97903437T patent/ES2163730T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU716691B2 (en) | 2000-03-02 |
| JP2000505442A (ja) | 2000-05-09 |
| DE69707104T2 (de) | 2002-06-20 |
| EP0880528A1 (de) | 1998-12-02 |
| DE69707104D1 (de) | 2001-11-08 |
| AU1799297A (en) | 1997-09-02 |
| WO1997030055A1 (en) | 1997-08-21 |
| ES2163730T3 (es) | 2002-02-01 |
| EP0880528B1 (de) | 2001-10-04 |
| US6127365A (en) | 2000-10-03 |
| GB9603137D0 (en) | 1996-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69616480D1 (de) | Piperidinderivate als neurokininantagonisten | |
| DE122008000037I1 (de) | Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten | |
| ATE170174T1 (de) | Gem-bissubstituierte azazyclische tachykinin- antagonisten | |
| ATE247096T1 (de) | Tetrahydropyranderivate und deren verwendung als therapeutische mittel | |
| EA199900045A1 (ru) | Производные спиропиперидина и их использование в качестве терапевтических агентов | |
| ATE340781T1 (de) | Cyclohexylderivate und ihre anwendung als therapeutische mittel | |
| NZ325449A (en) | Naphthyl-substituted benzimidazole derivatives as anticoagulants | |
| SE9604786D0 (sv) | New compounds | |
| EA200000911A1 (ru) | Новые кристаллические формы антивирусного соединения бензимидазола | |
| ATE119520T1 (de) | Derivate von hydroxaminsäure und von n- hydroxyharnstoff sowie ihre verwendung. | |
| ATE320432T1 (de) | Spiro-azacyclische derivate, deren herstellung und verwendung als tachykinin-antagonisten | |
| ATE169001T1 (de) | Substituierte spiro-azaringen als tachykinine rezeptor antagonisten | |
| DK0882021T3 (da) | Nye phenanthridiner | |
| TR199900856T2 (xx) | Bron�la ilgili terapi maddeleri olarak benzonaftiridinler | |
| EA200200132A1 (ru) | СЕЛЕКТИВНЫЕ АНТАГОНИСТЫ РЕЦЕПТОРА iGluRДЛЯ ЛЕЧЕНИЯ МИГРЕНИ | |
| ATE206428T1 (de) | Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe | |
| ES2135769T3 (es) | Derivados de isotiourea como inhibidores de no-sintasa. | |
| EE200200337A (et) | Uued ühendid ning nende kasutamine | |
| BG105710A (en) | 5ht1 antagonists for antidepressant therapy | |
| DE69512940D1 (de) | N-hydroxy-harnstoff-derivate als entzündunghemmende mittel | |
| ATE187956T1 (de) | Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel | |
| TR199901395T2 (xx) | Yeni karboksi ikameli siklik karboksamid t�revleri. | |
| PL343848A1 (en) | Novel benzimidazoles and benzoxazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |